These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8331207

  • 1. Pharmacokinetics of intravenous and intraperitoneal ceftazidime in chronic ambulatory peritoneal dialysis.
    Demotes-Mainard F, Vinçon G, Ragnaud JM, Morlat P, Bannwarth B, Dangoumau J.
    J Clin Pharmacol; 1993 May; 33(5):475-9. PubMed ID: 8331207
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H, Ragnaud JM, Demotes-Mainard F, Vinçon G, Couzineau M, Wone C.
    Eur J Clin Pharmacol; 1986 May; 31(4):479-83. PubMed ID: 3816928
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
    Albin H, Ragnaud JM, Demotes-Mainard F, Vincon G, Wone C.
    Eur J Clin Pharmacol; 1986 May; 30(3):299-302. PubMed ID: 3732364
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC, Demotes-Mainard FM, Bouchet JL, Vincon GA, Martin-Dupont C.
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
    Grabe DW, Bailie GR, Eisele G, Frye RF.
    Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
    [Abstract] [Full Text] [Related]

  • 6. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
    Peerapornratana S, Chariyavilaskul P, Kanjanabuch T, Praditpornsilpa K, Eiam-Ong S, Katavetin P.
    Perit Dial Int; 2017 Jan; 37(2):218-224. PubMed ID: 27738089
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
    Bouchet JL, Albin H, Quentin C, de Barbeyrac B, Vinçon G, Martin-Dupont P, Potaux L, Aparicio M.
    Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
    [Abstract] [Full Text] [Related]

  • 8. Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis.
    Stea S, Bachelor T, Cooper M, de Souza P, Koenig K, Bolton WK.
    J Am Soc Nephrol; 1996 Nov; 7(11):2399-402. PubMed ID: 8959631
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacokinetics of ceftazidime injected peritoneally in continuous ambulatory peritoneal dialysis].
    Ryckelynck JP, Vergnaud M, Hurault de Ligny B, Allouche G, Malbruny B, Morel C.
    Pathol Biol (Paris); 1986 May; 34(5):328-31. PubMed ID: 3534700
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Manley HJ, Bailie GR, Asher RD, Eisele G, Frye RF.
    Perit Dial Int; 1999 May; 19(1):65-70. PubMed ID: 10201343
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
    Dahl NV, Foote EF, Searson KM, Fein JL, Kapoian T, Steward CA, Sherman RA.
    Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetics of piperacillin during continuous ambulatory peritoneal dialysis].
    Ryckelynck JP, Debruyne D, Hurault De Ligny B, Moulin M.
    Pathol Biol (Paris); 1988 May; 36(5):507-10. PubMed ID: 3043348
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic profiles of ceftazidime after intravenous administration in patients undergoing automated peritoneal dialysis.
    Kim K, Hwang YH, Ro H, Oh YK, Kim MG, Yu KS, Shin KH, Jang IJ, Shin SG, Ahn C, Oh KH.
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2523-7. PubMed ID: 21402833
    [Abstract] [Full Text] [Related]

  • 14. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
    Sisterhen LL, Stowe CD, Farrar HC, Blaszak CK, Blaszak RT.
    Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
    [Abstract] [Full Text] [Related]

  • 15. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
    Triyawatanyu P, Chariyavilaskul P, Phaisal W, Peerapornratana S, Kanjanabuch T, Praditpornsilpa K, Katavetin P.
    Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189
    [Abstract] [Full Text] [Related]

  • 16. Absorption and clearance of ceftazidime during CAPD.
    Plant WD, Martin U, Barron W, Scouse PK, Winney RJ, Prescott LF.
    Perit Dial Int; 1995 Mar; 15(8):378-82. PubMed ID: 8785241
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.